Gilead Sciences Aktie

88,97 EUR +1,96 EUR +2,25 %

20.12.2024

FSE

92,57 USD +1,46 USD +1,60 %

nachbörslich20.12.2024

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.110,57 Mrd. EUR

KGV17,99Div. Rendite3,70%

WKN885823

ISINUS3755581036

SymbolGILD

Gilead Sciences Aktien News

Sortieren:Datum Meistgelesen

13.02.24BenzingaCymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst

13.02.24ZacksGilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline

12.02.24BenzingaDow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B

12.02.24BenzingaHealth Care Company Gilead Sciences Announces Acquisition of CymaBay Therapeutics

12.02.24MarketWatchCymaBay’s stock surges as Gilead reaches $4.3 billion deal for liver-drug developer

12.02.24BenzingaDrugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B

09.02.24ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO

07.02.24MotleyFoolWhy Gilead Sciences Stock Dropped Today

07.02.24ZacksGilead (GILD) Q4 Earnings Miss Estimates, Sales Top on Veklury

07.02.24MotleyFoolGilead Sciences (GILD) Q4 2023 Earnings Call Transcript

07.02.24ZacksGilead (GILD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

06.02.24BenzingaWhy Gilead Sciences Stock Is Trading Lower After The Bell

05.02.24BenzingaPreview: Gilead Sciences's Earnings

02.02.24ZacksGilead (GILD) Gears Up to Report Q4 Earnings: Whats in Store?

01.02.24ZacksExploring Analyst Estimates for Gilead (GILD) Q4 Earnings, Beyond Revenue and EPS

31.01.24ZacksIs Eventide Gilead Fund N (ETGLX) a Strong Mutual Fund Pick Right Now?

30.01.24ZacksGilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?

30.01.24BenzingaPharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

29.01.24ZacksGilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why

18.01.24BenzingaAbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades'

18.01.24ZacksGilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts

12.01.24Benzinga$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today

12.01.24ZacksGilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

06.01.24ZacksGilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know

03.01.24Benzinga(GILD) - Analyzing Gilead Sciences's Short Interest

30.12.23ZacksGilead Sciences (GILD) Stock Moves -0.16%: What You Should Know

22.12.23BenzingaA Look Into Gilead Sciences Inc's Price Over Earnings

20.12.23PR NewswireRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

15.11.23PR NewswireARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP

28.07.23PR NewswireGILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

24.07.23PR NewswireCognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million

09.12.22PR NewswireArcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

10.11.22RSSForm 4 882095

02.11.22RSSForm 10-Q 882095

27.10.22RSSForm 8-K 882095

08.08.22RSSStatement of acquisition of beneficial ownership by individuals

05.08.22RSSInitial statement of beneficial ownership of securities

04.06.22PR NewswireEverest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

05.05.22RSSForm S-8 882095

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.